Technical Analysis for IMUC - Immunocellular Thera

Grade Last Price % Change Price Change
grade D 0.0203 12.15% 0.0022
IMUC closed up 12.15 percent on Tuesday, May 21, 2019, on 4 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical IMUC trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish 12.15%
Fell Below 50 DMA Bearish 12.15%
1,2,3 Retracement Bearish Bearish Swing Setup 12.15%
180 Bearish Setup Bearish Swing Setup 12.15%

Older signals for IMUC ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of various cancers. Its products include ICT-107, a dendritic cell (DC) immunotherapy for the treatment of diagnosed glioblastoma multiforme (GBM); ICT-140, a DC-based immunotherapy targets tumor associated antigens on ovarian cancer; and ICT-121, a DC-based immunotherapy targeting CD133 markers and CSCs to treat recurrent GBM and other solid tumor cancers. The company is developing Steam-to-T-Cell immunotherapies for the treatment of cancer. It has license agreements with California Institute of Technology and The Johns Hopkins University. The company was formerly known as Optical Molecular Imaging, Inc. and changed its name to ImmunoCellular Therapeutics, Ltd. in November 2006. ImmunoCellular Therapeutics, Ltd. is based in Westlake Village, California.
Medicine Health Biotechnology RTT Cancer Treatment Of Cancer Cancers Immunotherapy Oncology Cancer Immunotherapy Ovarian Cancer Immunotherapies Virotherapy Glioblastoma Brain Tumor Solid Tumor Cancers Northwest Biotherapeutics California Institute Of Technology Glioblastoma Multiforme Steam
Is IMUC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.05
52 Week Low 0.014
Average Volume 69,639
200-Day Moving Average 0.0
50-Day Moving Average 0.0237
20-Day Moving Average 0.0235
10-Day Moving Average 0.0227
Average True Range 0.0049
ADX 43.56
+DI 4.7826
-DI 14.3478
Chandelier Exit (Long, 3 ATRs ) 0.0113
Chandelier Exit (Short, 3 ATRs ) 0.0307
Upper Bollinger Band 0.0274
Lower Bollinger Band 0.0196
Percent B (%b) 0.09
BandWidth 33.191489
MACD Line -0.0008
MACD Signal Line -0.0002
MACD Histogram -0.0006
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0292
Resistance 3 (R3) 0.0297 0.0274 0.0277
Resistance 2 (R2) 0.0274 0.0251 0.0271 0.0272
Resistance 1 (R1) 0.0238 0.0237 0.0227 0.0233 0.0267
Pivot Point 0.0215 0.0215 0.0209 0.0212 0.0215
Support 1 (S1) 0.0179 0.0192 0.0168 0.0174 0.0139
Support 2 (S2) 0.0156 0.0178 0.0153 0.0134
Support 3 (S3) 0.0120 0.0156 0.0129
Support 4 (S4) 0.0115